AbbVie (ABBV) Other Operating Expenses (2012 - 2026)

AbbVie (ABBV) has 15 years of Other Operating Expenses data on file, last reported at $5.0 billion in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $5.0 billion, up 16.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 billion (up 22.22% YoY), and the FY2025 annual result was $241.0 million, up 3342.86% from the prior year.
• Other Operating Expenses advanced to $5.0 billion in Q1 2026 per ABBV's latest filing, from $217.0 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $5.0 billion in Q1 2026 and troughed at -$229.0 million in Q3 2022.
• A 5-year average of $958.3 million and a median of $96.5 million in 2023 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2022 and 2025: Other Operating Expenses tumbled 145.8% in 2022, then jumped 3000.0% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at $1.0 million in 2022, then jumped by 16800.0% to $169.0 million in 2023, then slumped by 95.86% to $7.0 million in 2024, then jumped by 3000.0% to $217.0 million in 2025, then surged by 2186.64% to $5.0 billion in 2026.
• Business Quant data shows ABBV's Other Operating Expenses at $5.0 billion in Q1 2026, $217.0 million in Q4 2025, and $24.0 million in Q2 2025.